SCHEMBL140702

SCHEMBL140702

[CH]=C[C]=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11820516 0.59
SCHEMBL6084247 0.58
SCHEMBL17316206 0.56
SCHEMBL713211 0.56
SCHEMBL2112584 0.56
SCHEMBL775491 0.56
Ethyne SCHEMBL5170988 0.54
SCHEMBL1225170 0.54
SCHEMBL43218 0.54
SCHEMBL3255100 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1004 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0063538-B1 PROSTAGLANDINS AND PROSTACYCLINS, THEIR PREPARATIONS AND PHARMACEUTICAL APPLICATIONS SCHERING AKTIENGESELLSCHAFT (DE) 1986-08-06 EP claimed
EP-0081945-A2 Substituted pyrimidinyl organophosphorus compounds, compositions thereof and methods of controlling pests UNIROYAL, INC. (US) 1983-06-22 EP claimed
US-3966900-A INSECTICIDES AIRWICK INDUSTRIES, INC. (US) 1976-06-29 US claimed
US-20240182865-A1 VISIBLE LIGHT POLYMERIZATION OF POLYETHYLENE GLYCOL (PEG) HYDROGELS STEM PHARM, INCORPORATED 2024-06-06 US disclosed
US-20240180941-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FLAGSHIP PIONEERING INNOVATIONS V INC (US) 2024-06-06 US disclosed
EP-4377311-A1 2-DIAZO-3-OXO-2,3-DIHYDROSPIRO[INDENE-1,9'-XANTHENE] DERIVATIVES AND SIMILAR COMPOUNDS AS PHOTOACTIVE FLUORESCENT COMPOUNDS FOR PROTEIN LABELING Eikon Therapeutics Inc. (US) 2024-06-05 EP disclosed
US-11998610-B2 Conjugates and methods of using the same FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2024-06-04 US disclosed
US-11981703-B2 Polynucleotide constructs SIRIUS THERAPEUTICS, INC. (US) 2024-05-14 US disclosed
US-20230381180-A1 SMALL MOLECULE MODULATORS OF KSR-BOUND MEK ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2023-11-30 US disclosed
US-11813272-B2 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2023-11-14 US disclosed
US-20230321083-A1 Inhibitors of GPR174 and Uses Thereof OMEROS CORP (US) 2023-10-12 US disclosed
WO-1998001484-A9 METHOD FOR PRODUCING CYCLOOLEFIN (CO)POLYMERS FOR TECHNICAL APPLICATIONS 1998-05-07 WO disclosed
WO-1998001483-A1 METHOD FOR PRODUCING CYCLOOLEFIN (CO)POLYMERS FOR USE IN OPTICAL DATA MEMORIES BAYER AKTIENGESELLSCHAFT (DE) 1998-01-15 WO disclosed
WO-1998001487-A1 METHOD FOR PRODUCING ELASTOMERS BAYER AKTIENGESELLSCHAFT (DE) 1998-01-15 WO disclosed
EP-0353752-B1 N-2, 3-butadienyl triaminoalkane derivatives MERRELL DOW PHARMA (US) 1994-01-05 EP disclosed
EP-0332387-B1 Triazole derivatives, their preparation and their use as fungicides SANKYO CO (JP) 1993-11-24 EP disclosed
US-4935449-A TREATING A MALARIAL INFECTION MERRELL DOW PHARMACEUTICALS INC. (US) 1990-06-19 US disclosed
EP-0353752-A1 N-2, 3-butadienyl triaminoalkane derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1990-02-07 EP disclosed
EP-0332387-A1 Triazole derivatives, their preparation and their use as fungicides Sankyo Company Limited (JP) 1989-09-13 EP disclosed
US-3966900-A INSECTICIDES AIRWICK INDUSTRIES, INC. (US) 1976-06-29 US disclosed